中医序贯疗法治疗全聋型暴聋病之气滞血瘀证的临床观察

Clinical observation of TCM sequential therapy in the treatment of total sudden sensorineural hearing loss with qi-stagnation and blood-stasis

研究中医序贯疗法治疗全聋型暴聋病之气滞血瘀证的疗效。选取2023年5月至2023年12月在常德市第一中医医院就诊的全聋型暴聋病中属气滞血瘀证的60例患者,按随机数字法随机分为单纯西医治疗组及中西序贯疗法联合西医治疗组。治疗10 d后观察患者的听力、耳鸣及中医症候积分改善情况及血液流变学指标。结果表明,中医序贯疗法联合西医治疗组的总有效率83.33%,单纯西医治疗组的总有效率53.33%,中医序贯疗法联合西医治疗组的疗效优于单纯西医治疗组,中医序贯疗法联合西医治疗组的耳鸣评分、中医症候积分评分、全血高切粘度(HBV)、全血低切粘度(LBV)、血浆黏度(PV)的改善优于单纯西医治疗组,并且两组间差异具有统计学意义(P<0.05)。中医序贯疗法治疗全聋型暴聋病之气滞血瘀证的疗效优于西医常规治疗,对全聋型患者预后听力有显著改善,并且无明显不良反应。

To study the effect of TCM sequential therapy on total deafness type sudden deafness with qi stagnation and blood stasis syndrome,from May 2023 to December 2023,60 patients of such kind in Changde First Hospital of Traditional Chinese Medicine were divided at random into pure western medicine group and TCM sequential therapy combined with pure western medicine group according to the random number method.After 10 days of treatment,the improvement of hearing,tinnitus,TCM syndrome score,coagulation function and hemorheology were observed.The total effective rate of the TCM sequential therapy combined with pure western medicine group was 83.33%,and the total effective rate of the pure western medicine group was 53.33%.The curative effect of the TCM sequential therapy combined with pure western medicine group was better than that of the pure western medicine group.The tinnitus score,TCM syndrome score,whole blood high shear rate(HPV),whole blood low shear rate(LBV)and plasma viscosity(PV)of the TCM sequential therapy combined with western medicine group were lower than those of the western medicine group.And the differences between the two groups were statistically valid(P<0.05).TCM sequential therapy combined with western medicine is superior to pure western medicine therapy in the treatment of total sudden sensorineural hearing loss with qi stagnation and blood stasis syndrome.It can significantly improve the prognosis of hearing in patients with total deafness,and there is no significant increase in adverse reactions.